Literature DB >> 21147228

Thinking outside the box: using metastasis suppressors as molecular tools.

Sophie Thiolloy1, Carrie W Rinker-Schaeffer.   

Abstract

Metastasis, the process in which tumor cells move from a primary tumor through the circulation, lodge, and grow in distant locations, is a significant contributor to cancer patient morbidity and mortality, yet remains poorly understood. The molecular processes regulating tumorigenicity and metastasis are distinguishable, suggesting that it is possible to design therapeutic interventions to specifically control metastasis formation. Metastasis suppressors, which specifically regulate metastasis, are being used in "reverse genetics" approaches to discover the phenotypic alterations caused by modulating their levels and/or activity. This strategy is allowing the identification of tumor-host interactions that are crucial for efficient colonization and their disruption can be targeted to suppress metastases formation. In this review we discuss studies addressing invasion and migration, key functions for both early and late in the metastatic process. Metastasis suppressor functions, which modulate lodging and subsequent colonization of the secondary site, are also described. In sum this review focuses on metastasis suppressors that have yielded insight into mechanisms controlling metastasis formation. These serve as platform for out of the box thinking which will enable the discovery of new paradigms in metastasis research.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147228     DOI: 10.1016/j.semcancer.2010.12.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  12 in total

Review 1.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 2.  Translating metastasis-related biomarkers to the clinic--progress and pitfalls.

Authors:  François-Clément Bidard; Jean-Yves Pierga; Jean-Charles Soria; Jean Paul Thiery
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

3.  Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.

Authors:  Russell O Bainer; Jennifer Taylor Veneris; S Diane Yamada; Anthony Montag; Mark W Lingen; Yoav Gilad; Carrie W Rinker-Schaeffer
Journal:  Clin Exp Metastasis       Date:  2012-02-21       Impact factor: 5.150

Review 4.  Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Authors:  Nicholas C Popescu; Steve Goodison
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

Review 5.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.

Authors:  S Zhang; X Wang; A O Osunkoya; S Iqbal; Y Wang; Z Chen; S Müller; Z Chen; S Josson; I M Coleman; P S Nelson; Y A Wang; R Wang; D M Shin; F F Marshall; O Kucuk; L W K Chung; H E Zhau; D Wu
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

7.  A genome-wide RNAi screen identifies FOXO4 as a metastasis-suppressor through counteracting PI3K/AKT signal pathway in prostate cancer.

Authors:  Bing Su; Lingqiu Gao; Catherine Baranowski; Bryan Gillard; Jianmin Wang; Ryan Ransom; Hyun-Kyung Ko; Irwin H Gelman
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

8.  SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.

Authors:  Silvia Esposito; Marco V Russo; Irma Airoldi; Maria Grazia Tupone; Carlo Sorrentino; Giulia Barbarito; Serena Di Meo; Emma Di Carlo
Journal:  Oncotarget       Date:  2015-07-10

Review 9.  Mechanisms of ovarian cancer metastasis: biochemical pathways.

Authors:  Kentaro Nakayama; Naomi Nakayama; Hiroshi Katagiri; Kohji Miyazaki
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

10.  Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.

Authors:  Joaquim Bosch-Barrera; Elia Sais; Noemí Cañete; Jordi Marruecos; Elisabet Cuyàs; Angel Izquierdo; Rut Porta; Manel Haro; Joan Brunet; Salvador Pedraza; Javier A Menendez
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.